SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-17-019437
Filing Date
2017-10-12
Accepted
2017-10-12 17:30:12
Documents
5
Period of Report
2017-10-11
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K atrs-8k_20171011.htm 8-K 46720
2 EX-99.1 PRESS RELEASE DATED OCTOBER 12, 2017 atrs-ex991_6.htm EX-99.1 17902
3 EX-99.2 FDA LETTER RECEIVED OCTOBER 11, 2017 atrs-ex992_8.htm EX-99.2 16321
4 GRAPHIC g201710122035050462660.jpg GRAPHIC 17898
5 GRAPHIC g201710122035075062509.jpg GRAPHIC 1831
  Complete submission text file 0001564590-17-019437.txt   109804
Mailing Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628
Business Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 609-359-3020
ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1208
Type: 8-K | Act: 34 | File No.: 001-32302 | Film No.: 171135192
SIC: 3841 Surgical & Medical Instruments & Apparatus
Assistant Director 10